<DOC>
	<DOCNO>NCT01375153</DOCNO>
	<brief_summary>Chronic heart failure accompany anorexia increase release B-type natriuretic peptide ( BNP ) ventricular myocytes . The pathophysiological mechanism link heart failure appetite-regulation remain unknown . This study aim examine impact exogenous BNP administration subjective rating hunger satiety , appetite-regulating hormone placebo-controlled cross-over study perform ten healthy human volunteer .</brief_summary>
	<brief_title>Brain Natriuretic Peptide Effects Appetite Regulating Hormones Endothelial Derived Peptides</brief_title>
	<detailed_description>This prospective , single blind randomize , placebo-controlled , cross-over study , conduct ten healthy volunteer . Each subject participate two study days/sessions , separate washout period least two week . The session last approximately 4.5 hour . The subject come fast overnight . Two intravenous cannula place right left antecubital vein infusion blood sampling , respectively . The subject receive intravenously placebo 3.0 pmol/kg/min human active BNP ( BNP-32 ) continuous intravenous infusion give 4 hour ( time point 0 240 minute ) . The order study drug randomize . During whole study session ( last 4.5 hour ) subject remain fasted confine bed rest . The change subjective rating hunger satiety time evaluate 100 mm visual analog scale ( VAS ) half-hourly ( time point 0 240 minute ) . Herewith subject rate feeling hunger ( Hunger-VAS form include question : How hungry feel ? Subjects require mark feeling hunger scale 0 100 mm ) satiety ( Satiety-VAS form include question : How satt feel ? Subjects require mark feeling hunger scale 0 100 mm ) . Blood sample withdraw twice baseline ( time point -5 minute 0 minute ) hourly afterwards . Samples immediately cool ice , centrifuge 3000 rpm 10 minute store -20Â°C later measurement ghrelin , peptide YY , adiponectin , corticotropin , cortisol , adrenaline , noradrenaline , insulin , adrenomedullin , endothelin , copeptin , growth differentiation factor 15 , BNP atrial natriuretic peptide . All assay perform use commercial radioimmunoassay enzyme-linked immunosorbent assay end study sample belong ( study day ) one subject measure within one kit . The change VAS hormone concentration time evaluate use repeated measurement analysis variance ( ANOVA ) use SPSS release 12.0.1 statistical software .</detailed_description>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Natriuretic Peptide , Brain</mesh_term>
	<criteria>Men age 18 40 year write informed consent BMI &lt; 25 kg/m2 concomitant diseases BNP level within normal range Normal renal function ( serum creatinine le 1.2 mg/dL and/or creatinin clearance great 80ml/min ) systolic blood pressure &lt; 90 mmHg impair glucose tolerance diabetes mellitus hyperthyroidism , hypothyroidism hepatic , renal cardiovascular disease malignancy history medical therapy within 3 week prior enrolment study history anaphylaxis</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>BNP administration</keyword>
	<keyword>appetite</keyword>
	<keyword>ghrelin</keyword>
	<keyword>PYY</keyword>
</DOC>